PR Newswire - Ascentage Pharma Announces Confidential Submission...
ROCKVILLE, Md. and SUZHOU, China, June 24, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK) announced that it has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securit...
Read More

ภาษาไทย
English